18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.
Fiche publication
Date publication
mai 2021
Journal
Annals of nuclear medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HOEFFEL Christine, Pr PAPATHANASSIOU Dimitri, Pr DELMER Alain
Tous les auteurs :
Morland D, Zizi G, Godard F, Gauchy AC, Durot C, Hoeffel C, Delmer A, Papathanassiou D, Durot E
Lien Pubmed
Résumé
18F-FDG PET/CT provides valuable informations regarding the prognosis of DLBCL. The aim of this study is to test a novel index based on cerebellar uptake to predict progression free survival in DLBCL patients.
Mots clés
Brain, Lymphoma, Positron-emission tomography, Prognosis
Référence
Ann Nucl Med. 2021 May 24;: